CS Paper Radar

Toward Contrast-Free Breast MRI: Improving Cancer Detection With Virtual Contrast Enhanced Imaging

Hongxi Chen, Sunwoo Kwak, Sanyukta Adap, Katerina Dodelzon, Paula Feldman, Mert R. Sabuncu

eess.IV cs.CV ·submitted 2026-10-29 18:54 UTC · v1

Abstract

Although contrast-enhanced (CE) breast MRI is an important tool for cancer detection, intravenous gadolinium administration introduces additional considerations for patients and clinical workflows. AI based virtual contrast enhanced (VCE) MRI could help identify patients for whom acquired CE imaging may be avoidable without compromising diagnostic performance. We developed a framework that combines non contrast (NC) and VCE MRI predictions for cancer detection. On the held-out test set, cancer detection using NC MRI alone achieved an AUROC of 0.865. Combining the predictions from NC and VCE MRI improved AUROC to 0.901. Building on this complementary predictive value, we evaluated patient-level routing to progressively replace acquired CE examinations with the NC plus VCE pathway, prioritizing patients with the most confident NC predictions. This simulation suggests that diagnostic performance can be largely preserved while limiting acquired CE imaging to approximately 40% of patients. Together, these findings demonstrate the complementary value of VCE MRI and suggest its potential to support selective contrast use in breast cancer screening.

Comment
5 pages, 2 figures, 1 table. Submitted to ISBI 2027

Closest papers

Nearest neighbours by meaning across the whole index.

Lesion-Gated Hybrid Synthesis for Virtual Contrast-Enhanced Breast MRI: A MAMA-SYNTH Challenge Solution

eess.IV cs.CV ·2026-09-18 ·Shohei Yoshimoto
benchmark similarity 0.70
Abstract · 8 pages, 2 figures, 3 tables. MAMA-SYNTH Challenge solution report; the submitted method ranked 6th in the official challenge leaderboard

Purpose: Contrast-enhanced breast MRI depends on intravenous gadolinium-based contrast agents, motivating methods that synthesise post-contrast appearance from pre-contrast images alone. The MAMA-SYNTH Challenge (MICCAI 2026 Deep-Breath Workshop) evaluates such synthesis across four metric groups: image fidelity, tumour region of interest, downstream classification, and downstream segmentation. The four group ranks are averaged, so optimising a single objective is insufficient. Materials and Methods: We developed a lesion-gated hybrid synthesis pipeline. A lesion probability map, estimated from the pre-contrast slice alone by an ensemble of pre-contrast-only segmentation networks, spatially coordinates a tumour-focused regression pathway and a background-focused Pix2PixHD synthesis pathway, followed by a region-dependent calibration of the predicted enhancement. Training used the public MAMA-MIA collection with a patient-level split. Inference consumes a single pre-contrast 2D slice, with no mask, no post-contrast image, and no auxiliary metadata beyond image geometry. Results: On internal validation (n = 120 patients) the method reached MSE 0.523, LPIPS 0.185, and tumour-region SSIM 0.495. It was submitted to the hidden external 300-case test cohort as a self-contained inference container. The method ranked sixth in the official MAMA-SYNTH Challenge leaderboard. Conclusion: A test-compatible lesion probability map derived from the pre-contrast image can coordinate complementary tumour-focused regression and background-focused perceptual synthesis, enabling balanced virtual contrast enhancement under a multi-metric challenge setting.

0.20

Anatomy-Aware Synthesis of Post-Contrast Breast MRI from Pre-Contrast Images

cs.CV ·2026-09-22 ·Zhengbo Zhou, Dooman Arefan, Lin Gu, Ufara Zuwasti Curran, Shandong Wu
similarity 0.63
Abstract

We developed an anatomy-aware deep learning framework to synthesize post-contrast breast MRI from pre-contrast images, emphasizing tumor and background parenchymal enhancement (BPE) regions. This retrospective study included 649 patients with 6,251 paired pre-contrast and post-contrast images. The framework integrates breast mask consistency, lesion-region supervision, and BPE-region supervision into an image-to-image translation model. Evaluation included quantitative image quality metrics, a reader study with two breast radiologists, and downstream Ki-67 classification. The proposed method outperformed Pix2Pix, Pix2PixHD, diffusion-based synthesis, and mask-supervised baselines in whole-image and regional evaluations. Ki-67 classification showed no statistically significant performance differences across real- and synthetic-image training and testing settings, although this does not establish equivalence. These findings suggest that anatomy-aware supervision improves synthesis fidelity and support further investigation of synthetic post-contrast MRI for contrast-free imaging workflows.

0.13

Anguinus Sculpturae: Compositional Synthesis of Peak-Enhancement Breast DCE-MRI Scans

cs.CV ·2026-09-27 ·Benjamin Hamm, Nico Albert Disch, Maximilian Rokuss, Yannick Kirchhoff, Constantin Ulrich +1 more
publishedcode/data similarity 0.62
Abstract · Accepted as an oral at the MAMA-SYNTH 2026 challenge / Deep-BreAth 2026 Workshop, MICCAI 2026. 12 pages, 3 figures, 1 table

Dynamic contrast-enhanced breast MRI (DCE-MRI) is rich in anatomical and perfusion information, but its reliance on gadolinium-based contrast agents raises safety concerns and adds cost. Virtual contrast enhancement, synthesizing post-contrast from pre-contrast images, is a promising alternative. We address the MAMA-SYNTH challenge task of predicting peak-enhancement breast MRI. Rather than adopting the full machinery of diffusion or flow matching, we observe that under a rectified, straight-line path the generative process collapses to a single difference prediction: the synthetic peak image is the pre-contrast image plus a predicted enhancement map, recovered in one forward pass. Around this we build Anguinus Sculpturae, a compositional pipeline in which nnU-Net segmentations of lesion, foreground and breast region guide two generators - one optimized for global fidelity, one for lesion structure through an asymmetric Tversky term routed via a frozen segmenter - composited region-wise with Gaussian-weighted blending. On the held-out Duke subset of MAMA-MIA our model achieves the best FRD and Dice among all evaluated variants, showing that single-step difference prediction with segmentation guidance suffices to recover both global fidelity and lesion structure. Code is available at https://github.com/MIC-DKFZ/AnguinusSculpturae.

0.31

Evaluating ADC-only deep learning pipelines for breast cancer detection and segmentation using standalone diffusion-weighted MRI

cs.CV cs.AI ·2026-08-18 ·Pablo García Marcos, Paula Puerta Gonzĺez, Guillermo Lorenzo, Héctor Gómez, Covadonga del Camino +2 more
similarity 0.62
Abstract

Dynamic contrast-enhanced (DCE) imaging is the gold standard technique for the detection and characterization of breast cancer using magnetic resonance imaging (MRI). However, DCE-MRI requires long acquisition times and the administration of contrast into the bloodstream, which can cause allergic reactions. Alternatively, diffusion-weighted MRI (DW-MRI) is a standard complementary technique for breast MRI that does not require contrast, has shorter acquisition times, and enables calculation of apparent diffusion coefficient (ADC) maps that correlate with tumor cellularity. Yet, despite these technical advantages, deep learning research has focused on DCE-based models and has barely explored the tumor detection performance of DW-MRI and ADC maps either in combination with DCE-MRI or as standalone alternatives. Here, we evaluate the application of different state-of-the-art deep learning techniques for detection and segmentation of breast cancer using ADC-only images. This is, to our knowledge, the first comprehensive evaluation of ADC-only breast cancer pipelines for classification, detection, and segmentation tasks.

0.26

Subtraction-Based Tumor Segmentation and Lesion-Centered pCR Prediction for the MAMA-MIA Challenge

cs.CV cs.AIcs.LG ·2026-08-29 ·Kai Geissler, Raphael Schäfer
code/data similarity 0.61
Abstract

We describe the submission of team FME to the MAMA-MIA Challenge, which evaluated primary tumor segmentation and prediction of pathological complete response (pCR) from pretreatment dynamic contrast-enhanced breast MRI on an external multi-country cohort. For segmentation, we trained a five-fold residual-encoder nnU-Net ensemble using only the first post-contrast minus pre-contrast image, combined with mirroring test-time augmentation and largest-connected-component filtering. For pCR prediction, we ensembled 25 pretrained 3D video classifiers trained on lesion-centred crops from the pre-contrast and first two post-contrast volumes. FME ranked second in both tasks. The segmentation method achieved a combined performance-fairness score of 0.882, with Dice 0.713 and normalized Hausdorff distance 0.099. The pCR method achieved a combined score of 0.664, balanced accuracy of 0.541, and equalized-odds disparity of 0.212. The results indicate that subtraction-based input and ensembling support robust tumor segmentation under cross-site domain shift, whereas pCR prediction from baseline DCE-MRI alone remains limited. For the submission repository, see https://github.com/FraunhoferMEVIS/MAMA-MIA-Challenge-FME

0.35

Neoadjuvant chemotherapy response prediction using pretreatment diffusion and contrast-enhanced magnetic resonance imaging with clinical variables

cs.AI cs.CV ·2026-08-18 ·Pablo García Marcos, Paula Puerta González, Guillermo Lorenzo, Héctor Gómez, Covadonga del Camino +4 more
similarity 0.61
Abstract

Prediction of pathological complete response before neoadjuvant chemotherapy may facilitate more tailored therapeutic planning for breast cancer patients. This work proposes a deep-learning model for pretreatment data only, combining apparent diffusion coefficient maps, dynamic contrast-enhanced magnetic resonance imaging, and clinical variables. The study uses the public ACRIN 6698/I-SPY2 multicenter dataset. The architecture employs EfficientNet-B0 pretrained encoders for image feature extraction and late fusion with clinical information. Multiple clinical variables were evaluated, including age, race, histological type, HR/HER2 subtype, SBR grade, and maximum diameter. Only HR/HER2 subtype improved the average area under the receiver operating characteristic curve (AUC) and was retained in the final model. Using stratified five-fold cross-validation, standalone apparent diffusion coefficient maps achieved a mean AUC of 0.79, whereas dynamic contrast-enhanced magnetic resonance imaging achieved 0.74. Adding HR/HER2 subtype improved performance to 0.83 and 0.81, respectively. The final configuration, using both imaging modalities and HR/HER2 subtype, achieved an AUC of 0.86. These results support pretreatment multimodal learning for response prediction, although external validation is required before clinical use.

0.27

MAMA-FLUX.2: Image-to-Image Synthesis of Post-Contrast Breast DCE-MRI for the MAMA-SYNTH Challenge

cs.CV ·2026-08-26 ·Kamil Kwarciak, Marek Wodzinski
similarity 0.60
Abstract · 9 pages, 3 figures, 1 table

Dynamic contrast-enhanced breast MRI is central to cancer diagnosis and monitoring, but requires gadolinium-based contrast agents. In this work, we address pre-to-post contrast breast MRI synthesis for the MAMA-SYNTH challenge. We propose MAMA-FLUX.2, a conditional latent flow-matching approach based on FLUX.2-Klein-4B. The pre-contrast image is encoded as spatial conditioning, while the model predicts the flow field associated with the post-contrast target latent. To adapt the pretrained model efficiently, we use LoRA fine-tuning and introduce a regional training objective combining global flow matching, tumor-region supervision, and stable foreground regularization. We further investigate LoRA rank, intensity windowing, and regional loss weights on axial slices, prioritizing clinically relevant tumor-focused metrics. Our ablation study shows that moderate tumor and stable-foreground weighting improves the trade-off between image fidelity and tumor-region accuracy. The final model achieves the best overall balance with LoRA rank/$α=64/64$, $\mathrm{MHA}_{\max}=25$, $λ_{\mathrm{tumor}}=0.25$, and $λ_{\mathrm{stable}}=0.1$. These results demonstrate that compact pretrained rectified-flow transformers can be adapted for contrast-enhanced MRI synthesis using parameter-efficient fine-tuning and task-aware regional losses.

0.29

Pathology Randomization for Synthetic Priors and Zero-Shot Detection

cs.CV cs.AIeess.IV ·2026-11-16 ·Alexandra G. Roberts, Tonmoy Hossain, Mark Olchanyi, Stefan Brandstätter, Jonathan Williams Ramirez +5 more
benchmarkcode/data similarity 0.59
Abstract · 25 pages, 9 figures, 13 tables (8-page main text with appendices). Code: https://github.com/agr78/Pathology-Randomizer

Hospital brain imaging archives hold a diverse array of pathology at sample sizes beyond prospective studies, particularly for underrepresented populations and diseases. To unlock uncurated clinical data and scale analysis, methods are needed to detect abnormalities across contrasts and resolutions. Synthetic data has provided robust, contrast-agnostic models for a variety of human neuroimaging tasks in healthy anatomy, but pathology detection and other tasks in clinical settings still require real patient data, contrast-specific models, or disease-specific generators. We propose PathoDraw, a generative model of brain MRI with pathology. A conditional distribution of lesions given the healthy anatomy is drawn into the label map before contrast-agnostic rendering, and a single network estimates healthy anatomy with exact signed intensity deviation of any input scan. The contrast-agnostic 3D UNet learns the healthy labels under the lesion and the signed deviation directly and identifies pathology via robust tissue statistics and learned features, despite no training on real pathology. We show zero-shot detection on public stroke, tumor, and white matter hyperintensity datasets as well as archived clinical data, spanning $T_1$w, FLAIR and $T_2$w at various resolutions under a recent unsupervised anomaly detection benchmark protocol. Our single model exceeds or performs comparably to contrast-specific anomaly detectors trained on real scans and keeps healthy anatomy intact. The same generator trains networks for super-resolution and for registration in the presence of pathology. Our model, robust across acquisition and disease, enables the use of uncurated, archived data for clinical analysis. Our code is available at https://github.com/agr78/Pathology-Randomizer.

0.37